Valeriani Nicholas J

Director at EW; VP, Strategy & Growth at JNJ

Sold, on record
$2.4M
Dollars the filings state
Form 4 sales
3
Latest Feb 4, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • EWEdwards Lifesciences CorpDirector
  • JNJJOHNSON & JOHNSONVP, Strategy & Growth

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

  • JNJ25,200 shares
  • EW8,200 shares

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale JNJUnusual
    Nov 21 2007

    Sold 14,600 shares at $67.50 ($986k)

    Valeriani Nicholas J, Member, Executive Committee

    Sold 26.2% of holdings ($3.8M position)41,207 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale JNJPlan not stated
    Aug 6 +259 days

    Sold 10,600 shares at $71.14 ($754k)

    Valeriani Nicholas J, VP, Strategy & Growth

    Sold 16.6% of holdings ($4.5M position)53,318 shares leftFiling

  3. 3 Form 4 sale EWPlan not stated
    Feb 4 +4565 days

    Sold 8,200 shares at $85.21 ($699k)

    Valeriani Nicholas J, Director

    Sold 12.1% of holdings ($5.8M position)59,696 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Valeriani Nicholas J
Source
Feb 4, 2021EWDirectorForm 4 sale8,200$699k12.1%Plan not statedSEC
Aug 6, 2008JNJVP, Strategy & GrowthForm 4 sale10,600$754k16.6%Plan not statedSEC
Nov 21, 2007JNJMember, Executive CommitteeForm 4 sale14,600$986k26.2%UnusualSEC